普萘洛尔与拉贝洛尔：疗效上的有趣差异。 - Suppr

Suppr

超能文献

Propranolol versus labetalol: interesting differences in efficacy.

作者信息

Flamenbaum W

出版信息

J Natl Med Assoc. 1985 May;77 Suppl(Suppl):14-23.

PMID:3889356

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2561791/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce4/2561791/e4520a0c898c/jnma00249-0016-a.jpg

相似文献

Propranolol versus labetalol: interesting differences in efficacy.普萘洛尔与拉贝洛尔：疗效上的有趣差异。

J Natl Med Assoc. 1985 May;77 Suppl(Suppl):14-23.

A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.拉贝洛尔与普萘洛尔治疗原发性高血压患者的双盲交叉临床试验。

Int J Clin Pharmacol Ther Toxicol. 1985 Feb;23(2):101-4.

Comparison of labetalol and propranolol in hypertension.拉贝洛尔与普萘洛尔治疗高血压的比较。

Br J Clin Pharmacol. 1980 Mar;9(3):233-7. doi: 10.1111/j.1365-2125.1980.tb04832.x.

Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.拉贝洛尔、肼屈嗪和普萘洛尔治疗中度高血压的比较。

Med J Aust. 1980 Mar 8;1(5):224-5.

A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.拉贝洛尔（柳胺苄心定）、普萘洛尔与安慰剂治疗轻至中度高血压的对照试验

Br J Clin Pharmacol. 1979 Jan;7(1):63-8. doi: 10.1111/j.1365-2125.1979.tb00898.x.

[Comparative study of labetolol and propranolol in patients with untreated hypertension].拉贝洛尔与普萘洛尔治疗未经治疗的高血压患者的对比研究

Tidsskr Nor Laegeforen. 1981 Mar 30;101(9-10):579-81.

Comparison of labetalol and propranolol in treatment of hypertension.拉贝洛尔与普萘洛尔治疗高血压的比较。

Postgrad Med J. 1980;56 Suppl 2:65-8.

Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.拉贝洛尔的降压作用及血浆水平。与普萘洛尔和双肼屈嗪的比较。

Int J Clin Pharmacol Biopharm. 1979 Feb;17(2):71-5.

Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.拉贝洛尔和普萘洛尔治疗黑人高血压的成本效益

J Natl Med Assoc. 1987 Oct;79(10):1049-55.

Controlled comparison of labetalol and propranolol in the management of severe hypertension.拉贝洛尔与普萘洛尔治疗重度高血压的对照比较。

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):777-82.

引用本文的文献

Behavioral efficacy of propranolol in black patients.普萘洛尔对黑人患者的行为疗效。

J Natl Med Assoc. 1987 Feb;79(2):221-2.

Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors.血管紧张素转换酶抑制剂治疗黑人患者的高血压

J Natl Med Assoc. 1988 Mar;80(3):265-72.

本文引用的文献

Direct vasodilatation by labetalol in anaesthetized dogs.拉贝洛尔对麻醉犬的直接血管舒张作用。

Br J Pharmacol. 1980 Oct;70(2):287-93. doi: 10.1111/j.1476-5381.1980.tb07934.x.

Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients.

Angiology. 1981 Aug;32(8):561-6. doi: 10.1177/000331978103200806.

Responses to captopril and hydrochlorothiazide in black patients with hypertension.

Clin Pharmacol Ther. 1982 Sep;32(3):307-12. doi: 10.1038/clpt.1982.165.

Does a renal vasodilator system mediate racial differences in essential hypertension?肾血管舒张系统是否介导原发性高血压的种族差异？

Am J Med. 1980 Sep;69(3):425-9. doi: 10.1016/0002-9343(80)90015-7.

Metabolic consequences of antihypertensive therapy.

Ann Intern Med. 1983 May;98(5 Pt 2):875-80. doi: 10.7326/0003-4819-98-5-875.

Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man.新型降心率药物阿利尼定对人体心率和血压的影响。

J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):213-20. doi: 10.1097/00005344-198203000-00008.

Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.拉贝洛尔的一种异构体及其他血管舒张性β-肾上腺素受体阻滞剂的降压作用

Fed Proc. 1983 Feb;42(2):176-81.

Labetalol and lipids.

Lancet. 1981 Jan 17;1(8212):163. doi: 10.1016/s0140-6736(81)90759-5.

The clinical meaning of cardiovascular beta-adrenergic receptors.

Physiol Pharmacol Physicians. 1966 Nov;1(11):1-5.

Ineffectiveness of propranolol in hypertensive Jamaicans.普萘洛尔对牙买加高血压患者无效。

Br Med J. 1968 Jun 8;2(5605):601-3. doi: 10.1136/bmj.2.5605.601.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验